Madalene buys JNJ 105.42: Roche to purchase U.S. biotech firm Seragon for up to $1.7 bln, (NYSE: JNJ)
Roche Holding AG said it would pay up to $1.725 billion to purchase Seragon Pharmaceuticals, a privately-held U.S. biotech company that researches breast cancer treatments.Roche has long dominated the field of breast cancer with drugs such as Herceptin and ... ...
48 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home